A new study conducted by researchers at Weill Cornell Medical College and published in the New England Journal of Medicine suggests that painful chemotherapy could be avoided for patients suffering from chronic lymphocytic leukemia (CLL) thanks to a twice-daily pill that could aid in the treatment of a deadly blood cancer. CLL is the most common form of leukemia, a cancer of the white blood cells. Some 16,000 Americans are diagnosed with CLL annually, and about ...
Read More
No comments:
Post a Comment